Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors
F Barbieri, M Cagnoli, N Ragni, et al.
The Journal of General Virology
|
February 1, 1983
Host range differences among xenotropic type C retroviruses isolated from mouse kidney cell cultures
O E Varnier, C M Repetto, S P Raffanti, et al.
Basic and Applied Histochemistry
|
January 1, 1986
Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapy
P F Conte, A Alama, E Di Marco, et al.
Pharmacological Research
|
September 1, 1990
Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activity
A Alama, F Barbieri, G Gardin, et al.
Anti-Cancer Drugs
|
April 1, 1993
Oligonucleotide degradation contributes to resistance to antisense compounds
A Ryte, S Morelli, M Mazzei, et al.
Anticancer Research
|
May 16, 2000
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound
F Barbieri, M Viale, F Sparatore, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1994
In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma
E Baldini, P G Giannessi, G Gardin, et al.
Anticancer Research
|
May 1, 1990
Manipulation of the growth rate of human breast cancer cells by antiandrogen followed by chemotherapy
A Alama, L Miglietta, R E Favoni, et al.
Cancer Research
|
November 1, 1985
Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer
P F Conte, G Fraschini, A Alama, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma
A Alama, F Merlo, S Chiara, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 1999
Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors
F Barbieri, M Cagnoli, N Ragni, et al.
The Journal of General Virology
|
February 1, 1983
Host range differences among xenotropic type C retroviruses isolated from mouse kidney cell cultures
O E Varnier, C M Repetto, S P Raffanti, et al.
Basic and Applied Histochemistry
|
January 1, 1986
Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapy
P F Conte, A Alama, E Di Marco, et al.
Pharmacological Research
|
September 1, 1990
Diethylstilbestrol (DES) and recombinant human growth hormone (rhGH) as modulators of breast cancer proliferative activity
A Alama, F Barbieri, G Gardin, et al.
Anti-Cancer Drugs
|
April 1, 1993
Oligonucleotide degradation contributes to resistance to antisense compounds
A Ryte, S Morelli, M Mazzei, et al.
Anticancer Research
|
May 16, 2000
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound
F Barbieri, M Viale, F Sparatore, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1994
In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinoma
E Baldini, P G Giannessi, G Gardin, et al.
Anticancer Research
|
May 1, 1990
Manipulation of the growth rate of human breast cancer cells by antiandrogen followed by chemotherapy
A Alama, L Miglietta, R E Favoni, et al.
Cancer Research
|
November 1, 1985
Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer
P F Conte, G Fraschini, A Alama, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma
A Alama, F Merlo, S Chiara, et al.
Page
of 6